摘要
孕酮受体膜组分1和2,neudesin和neuferricin均属于膜孕激素受体(MAPR)家庭。最近,性类固醇膜受体因为潜在参与了性激素介导的快速非基因组的效应已获得了关注,目前尚不能解释核受体的基因组作用。孕酮可能通过包括丝裂原活化蛋白激酶的活化(MAPK)以及通过MAPRs的磷脂酰肌醇3激酶(PI3K)通路的非基因组效应来增加细胞的增殖和存活。此外,MAPRs独特的表达表明它们可能被用来作为生物标志物以及与性激素有关的癌症和其他疾病的药物靶点。在这篇综述中,我们总结了MAPRs的生理作用,提供一个全面的概述,关于他们的孕激素介导的非基因组作用的新见解,并讨论了其潜在的治疗靶点。
关键词: 孕酮;PGRMC1; PGRMC2;neudesin;neuferricin;癌症。
Current Drug Targets
Title:Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets
Volume: 17 Issue: 10
Author(s): Sae Hasegawa, Mayu Kasubuchi, Kazuya Terasawa, Ikuo Kimura
Affiliation:
关键词: 孕酮;PGRMC1; PGRMC2;neudesin;neuferricin;癌症。
摘要: Progesterone receptor membrane components 1 and 2, neudesin, and neuferricin belong to the membraneassociated progesterone receptor (MAPR) family. Recently, sex steroid membrane receptors have gained attention because of their potential involvement in sex hormone-mediated rapid non-genomic effects, which cannot currently be explained by the genomic action of nuclear receptors. Progesterone may increase cell proliferation and survival via nongenomic effects including the activation of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3- kinase (PI3K) pathways through MAPRs. Moreover, the unique expression of MAPRs suggests that they could be used as biomarkers and drug targets for sex steroid-related cancers and other diseases. In this review, we summarize the physiological roles of the MAPRs, provide a comprehensive overview of their progesterone-mediated non-genomic actions, and discuss new insights into their potential as therapeutic targets.
Export Options
About this article
Cite this article as:
Sae Hasegawa, Mayu Kasubuchi, Kazuya Terasawa, Ikuo Kimura , Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets, Current Drug Targets 2016; 17 (10) . https://dx.doi.org/10.2174/1389450116666150518102651
DOI https://dx.doi.org/10.2174/1389450116666150518102651 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Estrogens and Progression of Diabetic Kidney Damage
Current Diabetes Reviews One-pot Synthesis of 2-Hydroxy-1,4-Naphthoquinone (Lawsone)
Current Organic Synthesis Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Central Insulin and Insulin-Like Growth Factor-1 Signaling - Implications for Diabetes Associated Dementia
Current Diabetes Reviews Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
Current Medicinal Chemistry Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
Current Pharmaceutical Design Estrogen, Immunity & Autoimmune Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The IL-12 Family of Cytokines in Infection, Inflammation and Autoimmune Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Current Bioinformatics Meet the Editorial Board
Current Cancer Drug Targets Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery The Quest to Repair the Damaged Spinal Cord
Recent Patents on CNS Drug Discovery (Discontinued) The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations
Current Drug Targets Searching Drug-Like Anti-cancer Compound(s) Based on G-Quadruplex Ligands
Current Pharmaceutical Design Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design